Viewing StudyNCT00000737



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000737
Status: COMPLETED
Last Update Posted: 2008-08-25
First Post: 1999-11-02

Brief Title: A Phase III Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Organization Data

Organization: National Institute of Allergy and Infectious Diseases NIAID
Class: NIH
Study ID: DATRI 004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Bristol-Myers Squibb INDUSTRY
Roxane Laboratories INDUSTRY